Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 127
Filtrar
1.
Mar Drugs ; 17(2)2019 Feb 06.
Artículo en Inglés | MEDLINE | ID: mdl-30736370

RESUMEN

A new acylic jasplakinolide congener (2), another acyclic derivative requiring revision (4), together with two jasplakinolide derivatives including the parent compound jasplakinolide (1) were isolated from the Indonesian marine sponge Jaspis splendens. The chemical structures of the new and known compounds were unambiguously elucidated based on HRESIMS and exhaustive 1D and 2D NMR spectral analysis as well as a comparison of their NMR data with those of jasplakinolide (1). The isolated jasplakinolides inhibited the growth of mouse lymphoma (L5178Y) cells in vitro with IC50 values in the low micromolar to nanomolar range.


Asunto(s)
Depsipéptidos/química , Depsipéptidos/farmacología , Poríferos/química , Animales , Espectroscopía de Resonancia Magnética con Carbono-13 , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Depsipéptidos/aislamiento & purificación , Leucemia L5178/tratamiento farmacológico , Leucemia L5178/patología , Ratones , Espectroscopía de Protones por Resonancia Magnética
2.
Mar Drugs ; 15(11)2017 Nov 14.
Artículo en Inglés | MEDLINE | ID: mdl-29135916

RESUMEN

The marine-derived fungus Talaromyces rugulosus isolated from the Mediterranean sponge Axinella cannabina and cultured on solid rice medium yielded seventeen lactone derivatives including five butenolides (1-5), seven (3S)-resorcylide derivatives (6-12), two butenolide-resorcylide dimers (13 and 14), and three dihydroisocoumarins (15-17). Among them, fourteen compounds (1-3, 6-16) are new natural products. The structures of the isolated compounds were elucidated by 1D and 2D NMR (Nuclear Magnetic Resonance) spectroscopy as well as by ESI-HRMS (ElectroSpray Ionization-High Resolution Mass Spectrometry). TDDFT-ECD (Time-Dependent Density Functional Theory-Electronic Circular Dichroism) calculations were performed to determine the absolute configurations of chiral compounds. The butenolide-resorcylide dimers talarodilactones A and B (13 and 14) exhibited potent cytotoxicity against the L5178Y murine lymphoma cell line with IC50 values of 3.9 and 1.3 µM, respectively.


Asunto(s)
Lactonas/química , Poríferos/química , Talaromyces/química , 4-Butirolactona/análogos & derivados , 4-Butirolactona/química , 4-Butirolactona/farmacología , Animales , Productos Biológicos/química , Productos Biológicos/farmacología , Línea Celular Tumoral , Dicroismo Circular , Lactonas/farmacología , Leucemia L5178/tratamiento farmacológico , Ratones , Resonancia Magnética Nuclear Biomolecular/métodos
3.
Mol Biotechnol ; 58(8-9): 528-39, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27198565

RESUMEN

The modified asparaginase Was79 was derived from the recombinant wild-type L-asparaginase of Wolinella succinogenes. The Was79 contains the amino acid substitutions V23Q and K24T responsible for the resistance to trypsinolysis and the N-terminal heparin-binding peptide KRKKKGKGLGKKR responsible for the binding to heparin and tumor K562 cells in vitro. When tested on a mouse model of Fischer lymphadenosis L5178Y, therapeutic efficacy of Was79 was significantly higher than that of reference enzymes at all single therapeutic doses used (125-8000 IU/kg). At Was79 single doses of 500-8000 IU/kg, the complete remission rate of 100 % was observed. The Was79 variant can be expressed intracellularly in E. coli as a less immunogenic formyl-methionine-free form at high per cell production levels.


Asunto(s)
Antineoplásicos/administración & dosificación , Asparaginasa/genética , Asparaginasa/metabolismo , Heparina/metabolismo , Leucemia L5178/tratamiento farmacológico , Wolinella/enzimología , Sustitución de Aminoácidos , Animales , Antineoplásicos/farmacología , Asparaginasa/administración & dosificación , Asparaginasa/farmacología , Proteínas Bacterianas/administración & dosificación , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Proteínas Bacterianas/farmacología , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Humanos , Células K562 , Ratones , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacología , Wolinella/genética , Ensayos Antitumor por Modelo de Xenoinjerto
4.
Food Chem Toxicol ; 59: 187-90, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23778052

RESUMEN

The mouse lymphoma L5178Y Tk(+/-) assay is broadly used in toxicology to assess genotoxicity because of its known sensitivity to genotoxicants that act through a variety of mechanisms, which may include epigenetic DNA methylation. This brief article highlights the studies that have contributed to this conjecture and suggests an addition to the experimental design that could identify if the test substance is a potential epimutagen acting via hypermethylation.


Asunto(s)
Antimetabolitos Antineoplásicos/metabolismo , Represión Epigenética/efectos de los fármacos , Leucemia L5178/metabolismo , Pruebas de Mutagenicidad , Mutágenos/toxicidad , Proteínas de Neoplasias/metabolismo , Timidina Quinasa/metabolismo , Aminopterina/metabolismo , Aminopterina/farmacología , Animales , Antimetabolitos Antineoplásicos/farmacología , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Células Clonales , Metilación de ADN/efectos de los fármacos , Resistencia a Antineoplásicos/efectos de los fármacos , Estudios de Evaluación como Asunto , Hipoxantina/metabolismo , Leucemia L5178/tratamiento farmacológico , Leucemia L5178/enzimología , Ratones , Mutación/efectos de los fármacos , Proteínas de Neoplasias/genética , Timidina/metabolismo , Timidina Quinasa/genética , Trifluridina/metabolismo , Trifluridina/farmacología
5.
Regul Toxicol Pharmacol ; 65(2): 196-200, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23220485

RESUMEN

Particulate matter (PM) collected from mainstream tobacco smoke is a test article commonly used for in vitro genotoxicity and cytotoxicity testing of combustible tobacco products. However, little published data exists concerning the stability of PM. We completed a 2 year study to quantify the effect of PM storage at -80 °C, on the genotoxicity and cytotoxicity of PM generated from 3R4F and M4A reference cigarettes. The Ames test, Micronucleus assay (MNvit), Mouse Lymphoma assay (MLA) and the Neutral Red Uptake assay (NRU) were used. The majority of M4A and 3R4F PMs were genotoxic and cytotoxic at the timepoints tested. Some minor but statistically significant differences were observed for stored versus freshly prepared PM, but the magnitude of changes were within the variability observed for repeat testing.


Asunto(s)
Contaminantes Atmosféricos/toxicidad , Mutágenos/toxicidad , Material Particulado/toxicidad , Humo/efectos adversos , Contaminación por Humo de Tabaco/efectos adversos , Contaminantes Atmosféricos/clasificación , Animales , Células 3T3 BALB/efectos de los fármacos , Línea Celular , Supervivencia Celular/efectos de los fármacos , ADN/efectos de los fármacos , Daño del ADN , Estabilidad de Medicamentos , Concentración 50 Inhibidora , Leucemia L5178/tratamiento farmacológico , Leucemia L5178/genética , Ratones , Ratones Endogámicos BALB C , Pruebas de Micronúcleos , Mutágenos/clasificación , Rojo Neutro/metabolismo , Material Particulado/clasificación , Reproducibilidad de los Resultados , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/genética , Factores de Tiempo , Nicotiana
6.
Anticancer Res ; 32(7): 2863-9, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22753749

RESUMEN

BACKGROUND: Protoapigenone (PA), a natural flavonoid possessing an unusual p-quinol moiety on its B ring, is a prospective novel lead compound against cancer currently in development, together with WYC0209, a potent synthetic PA analog. Structure activity relationships (SAR) concerning different 1'-O-alkyl side-chains were also studied on two sets of derivatives. MATERIALS AND METHODS: Fifteen 1'-O-alkyl protoflavone derivatives were synthesized from genkwanin or 4'-hydroxy-6-methylflavone, thirteen of which are new compounds. All compounds were tested for their cytotoxic effect on four human cancer cell lines, such as HepG2 and Hep3B (hepatic), A549 (lung) and MDA-MB-231 (breast) cell lines, with doxorubicin as a positive control. All compounds, as well as PA, WYC0209 and fourteen of their previously reported analogs were also tested on a multidrug-resistant (MDR) sub-cell line of L5178 mouse T-cell lymphoma and on its parental counterpart (PAR). RESULTS: In general, derivatives bearing a free hydroxyl group at C-1' exerted the strongest activities, while C-1'-substituted compounds were found to be much weaker. Derivatives of 6-methylflavone exhibited mild, but statistically significant selectivity towards the MDR cell line. CONCLUSION: The results are in agreement with our previous findings for fundamental SAR of protoflavones. 6-Methylated protoflavones may serve as valuable leads for developing selective compounds against MDR cancer. Identical activity of other derivatives on the PAR and MDR cell lines suggests that cancer cells cannot exhibit resistance to protoflavones by ABCB1 efflux pump overexpression.


Asunto(s)
Antineoplásicos/farmacología , Flavonas/farmacología , Animales , Antineoplásicos/química , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Resistencia a Múltiples Medicamentos , Resistencia a Antineoplásicos , Ensayos de Selección de Medicamentos Antitumorales , Flavonas/química , Células Hep G2 , Humanos , Leucemia L5178/tratamiento farmacológico , Ratones , Relación Estructura-Actividad
7.
Anticancer Res ; 30(12): 4867-71, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21187464

RESUMEN

BACKGROUND: Hydantoin derivatives possess a variety of biochemical and pharmacological properties. Although hydantoin compounds are studied extensively, there are not many studies that investigate their anticancer properties. MATERIALS AND METHODS: Thirty hydantoin compounds were evaluated for their efflux modulating effects in cancer cells using a rhodamine 123 accumulation assay and real-time fluorometry based on the intracellular accumulation of ethidium bromide. RESULTS: The 30 derivatives were screened by real-time fluorometry for rhodamine 123 accumulation. Among the selected derivatives, compounds SZ-7, LL-9, BS-1, MN-3, P3, RW-15b, AD-26, RW-13, AD-29 and KF-2 significantly increased the retention of rhodamine 123. Compounds AD-26, AD-29, RW-13, KF-2, BS-1, MN-3, RW-15b and JH-63 showed synergistic effect with doxorubicin on mouse lymphoma cells. Furthermore, compound SZ-7 had indifferent effect with doxorubicin. CONCLUSION: These results indicated the role of chemical modifications within the hydantoin ring for its potential inhibition of the ABCB1 transporter. The most active structures contained aromatic substituents as well as some tertiary amine fragments.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/antagonistas & inhibidores , Transportadoras de Casetes de Unión a ATP/antagonistas & inhibidores , Hidantoínas/farmacología , Leucemia L5178/tratamiento farmacológico , Leucemia L5178/metabolismo , Subfamilia B de Transportador de Casetes de Unión a ATP , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Transportadoras de Casetes de Unión a ATP/metabolismo , Animales , Doxorrubicina/farmacocinética , Doxorrubicina/farmacología , Resistencia a Antineoplásicos , Sinergismo Farmacológico , Etidio/farmacocinética , Fluorometría , Humanos , Leucemia L5178/genética , Ratones , Rodamina 123/farmacocinética , Transfección
8.
BMC Complement Altern Med ; 10: 61, 2010 Oct 20.
Artículo en Inglés | MEDLINE | ID: mdl-20961452

RESUMEN

BACKGROUND: Recently, proteins and peptides have become an added value to foodstuffs due to new knowledge about its structural analyses as related to antioxidant and anticancer activity. Our goal was to evaluate if protein fractions from cacao seeds show antitumor activity on lymphoma murine L5178Y model. The antioxidant activity of these fractions was also evaluated with the aim of finding a correlation with the antitumor activity. METHODS: Differential extraction of proteins from unfermented and semi-fermented-dry cacao seeds was performed and characterized by SDS-PAGE and FPLC size-exclusion chromatography. Antitumor activity was evaluated against murine lymphoma L5178Y in BALB/c mice (6 × 104 cells i.p.), with a treatment oral dose of 25 mg/kg/day of each protein fraction, over a period of 15 days. Antioxidant activity was evaluated by the ABTS+ and ORAC-FL assays. RESULTS: Albumin, globulin and glutelin fractions from both cacao seed type were obtained by differential solubility extraction. Glutelins were the predominant fraction. In the albumin fraction, polypeptides of 42.3 and 8.5 kDa were found in native conditions, presumably in the form of two peptide chains of 21.5 kDa each one. The globulin fraction presented polypeptides of 86 and 57 kDa in unfermented cacao seed that produced the specific-cacao aroma precursors, and after fermentation the polypeptides were of 45 and 39 kDa. The glutelin fraction presented proteins >200 kDa and globulins components <100 KDa in lesser proportion. Regarding the semifermented-dry cacao seed, it was observed that the albumin fraction showed antitumoral activity, since it caused significant decreases (p < 0.05) in the ascetic fluid volume and packed cell volume, inhibiting cell growth in 59.98 ± 13.6% at 60% of the population; while the greatest antioxidant capacity due to free radical scavenging capacity was showed by the albumin and glutelin fraction in both methods assayed. CONCLUSION: This study is the first report on the biological activity of semifermented-dry cacao protein fractions with their identification, supporting the traditional use of the plant. The albumin fraction showed antitumor and free radical scavenging capacity, however both activities were not correlated. The protein fractions could be considered as source of potential antitumor peptides.


Asunto(s)
Albúminas/uso terapéutico , Antineoplásicos Fitogénicos/uso terapéutico , Antioxidantes/uso terapéutico , Cacao/química , Glútenes/uso terapéutico , Leucemia L5178/tratamiento farmacológico , Proteínas de Plantas/uso terapéutico , Albúminas/análisis , Albúminas/farmacología , Animales , Antineoplásicos Fitogénicos/análisis , Antineoplásicos Fitogénicos/farmacología , Antioxidantes/análisis , Antioxidantes/farmacología , Ascitis , Proliferación Celular/efectos de los fármacos , Tamaño de la Célula , Modelos Animales de Enfermedad , Fermentación , Globulinas/análisis , Glútenes/análisis , Glútenes/farmacología , Masculino , Ratones , Ratones Endogámicos BALB C , Péptidos/farmacología , Péptidos/uso terapéutico , Extractos Vegetales/análisis , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Proteínas de Plantas/análisis , Proteínas de Plantas/farmacología , Semillas
9.
Food Chem Toxicol ; 48(11): 3067-72, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20691239

RESUMEN

Sucralose is a non-nutritive sweetener that is approximately 600 times sweeter than table sugar. It is currently approved for use in over 80 countries. Evidence from chronic studies demonstrates that this compound is not carcinogenic. This report summarizes the results of genotoxicity studies that were part of the original safety assessment of sucralose-conducted early in the safety investigation and shared with regulatory agencies around the world. Studies included the Ames (Salmonella typhimurium) reverse mutation test, the Escherichia coli pol A+/A- test, an in vitro chromosome damage assay in human lymphocytes, mutation in TK +/- mouse lymphoma cells, an in vivo chromosome aberration test in rats and two separate micronucleus tests in mice. All results were evaluated as negative. These results support the overall conclusion by regulatory and heath agencies that sucralose is safe for its intended use.


Asunto(s)
Pruebas de Mutagenicidad/métodos , Mutágenos/toxicidad , Sacarosa/análogos & derivados , Edulcorantes/toxicidad , Animales , Supervivencia Celular/efectos de los fármacos , Aberraciones Cromosómicas/inducido químicamente , Daño del ADN , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Femenino , Humanos , Leucemia L5178/tratamiento farmacológico , Leucemia L5178/enzimología , Leucemia L5178/genética , Linfocitos/efectos de los fármacos , Masculino , Ratones , Micronúcleos con Defecto Cromosómico/inducido químicamente , Pruebas de Micronúcleos , Mutágenos/clasificación , Mutación , Ratas , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/genética , Sacarosa/clasificación , Sacarosa/toxicidad , Edulcorantes/clasificación , Timidina Quinasa/genética , Timidina Quinasa/metabolismo
10.
Anticancer Res ; 30(3): 829-35, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20393003

RESUMEN

A bioassay-guided separation protocol, including the testing of the extracts, fractions and pure compounds for their ability to inhibit P-glycoprotein (the efflux pump responsible for the multidrug resistance of the used cell line) of mouse lymphoma cells containing the human efflux pump gene MDR1, led to the isolation of seven compounds from the chloroform and ethyl acetate soluble fractions of the methanolic extract of Carpobrotus edulis. The compounds were identified by 1D, 2D NMR and MS investigations as triterpens (beta-amyrin, uvaol and oleanolic acid), monogalactosyldiacylglycerol, catechin, epicatechin and procyanidin B5. Uvaol was the most effective and promising compound in the reversal of multidrug resistance in MDR mouse lymphoma cell line.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/antagonistas & inhibidores , Aizoaceae/química , Linfoma de Células T/tratamiento farmacológico , Linfoma de Células T/metabolismo , Extractos Vegetales/farmacología , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Animales , Galactolípidos/farmacología , Humanos , Leucemia L5178/tratamiento farmacológico , Leucemia L5178/genética , Leucemia L5178/metabolismo , Linfoma de Células T/genética , Metanol/química , Ratones , Ácido Oleanólico/farmacología , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Hojas de la Planta/química , Rodamina 123/farmacocinética , Transfección , Triterpenos/farmacología
11.
Anticancer Res ; 29(11): 4467-72, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20032393

RESUMEN

BACKGROUND: One of the most promising strategies to overcome multidrug resistance (MDR) is to use compounds that can modulate P-glycoprotein and restore the cytotoxicity of anticancer drugs. Furthermore, the search for compounds that regulate and overcome apoptosis deficiency of cancer cells is also of great therapeutic importance. MATERIALS AND METHODS: Seven known pentacyclic triterpenes and one steroid were isolated from Euphorbia lagascae methanolic extracts and identified by physical and spectroscopic methods. These compounds, together with eleven terpenoids previously isolated from Euphorbia lagascae and E. tuckeyana were tested for their MDR-reversing and/or apoptosis induction activities by flow cytometry on L5178 human MDR1 gene-transfected mouse lymphoma cells. RESULTS: Four taraxastane-type triterpenes: 21alpha-hydroxytaraxasterol, 21alpha-hydroxytaraxasterol acetate, 3beta,30-dihydroxy-20(21)-taraxastene and 3beta-hydroxy-20-taraxasten-30-al, and two steroids: stigmastane-3,6-dione and ergosterol peroxide exhibited a significant MDR-Pgp modulation activity. Some aspects of structure-activity relationships are discussed. Regarding apoptosis induction, the most significant results were obtained for the polycyclic diterpenes ent-16alpha,17-dihydroxykauran-3-one and ent-16alpha,17-dihydroxyatisan-3-one.


Asunto(s)
Euphorbia/química , Terpenos/farmacología , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Animales , Apoptosis/efectos de los fármacos , Resistencia a Múltiples Medicamentos , Resistencia a Antineoplásicos , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Leucemia L5178/tratamiento farmacológico , Leucemia L5178/genética , Leucemia L5178/metabolismo , Leucemia L5178/patología , Ratones , Terpenos/aislamiento & purificación
12.
In Vivo ; 23(6): 943-7, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-20023237

RESUMEN

BACKGROUND: Overexpression of ATP-binding cassette (ABC) transporters such as P-glycoprotein (P-gp), multidrug resistance-associated protein 1 (MRP1) or breast cancer resistance protein (BCRP) accounts for majority of cases of multidrug resistance (MDR) of cancer cells. MATERIALS AND METHODS: In the present work, the interactions of seven commercially available phenothiazine derivatives, known P-glycoprotein inhibitors, with this transporter and MRP1 were compared. By flow cytometry, it was shown that all the drugs increased the accumulation of rhodamine 123 in the P-gp-overexpressing lymphoma cell line L5178 MDR. On the other hand, phenothiazine derivatives stimulated MRP1-mediated efflux of fluorescent probe (BCPCF) out of human erythrocytes. RESULTS: In this way, these phenothiazine derivatives were identified as a group of atypical MDR modulators that differently interact with P-gp (as inhibitors) and MRP1 (as stimulators). CONCLUSION: This observation clearly shows that the activity of all new modulators should be tested for their effects towards different ABC transporters as a standard procedure.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Leucemia L5178/tratamiento farmacológico , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/metabolismo , Fenotiazinas/farmacología , Animales , Línea Celular Tumoral , Resistencia a Múltiples Medicamentos , Resistencia a Antineoplásicos , Eritrocitos/efectos de los fármacos , Eritrocitos/metabolismo , Citometría de Flujo , Colorantes Fluorescentes/metabolismo , Humanos , Leucemia L5178/metabolismo , Ratones , Rodamina 123/metabolismo
13.
Z Naturforsch C J Biosci ; 64(5-6): 350-4, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19678537

RESUMEN

A hitherto unidentified endophytic strain of the genus Chaetomium, isolated from the medicinal plant Otanthus maritimus, yielded a new tetrahydrofuran derivative, aureonitolic acid (1), along with 5 known natural products, 2-6. The structure of 1 was determined by extensive spectroscopic analysis and comparison with reported data. Extracts of the fungus, grown either in liquid culture or on solid rice media, exhibited considerable cytotoxic activity when tested in vitro against L5178Y mouse lymphoma cells. Compounds 2 and 6 showed significant growth inhibition against L5178Y cells with EC50 values of 7.0 and 2.7 microg/mL, respectively, whereas 1 was inactive.


Asunto(s)
Asteraceae/microbiología , Chaetomium/química , Furanos/aislamiento & purificación , Furanos/farmacología , Animales , Antineoplásicos/química , Antineoplásicos/aislamiento & purificación , Antineoplásicos/farmacología , Línea Celular Tumoral/efectos de los fármacos , Chaetomium/aislamiento & purificación , Furanos/química , Leucemia L5178/tratamiento farmacológico , Espectroscopía de Resonancia Magnética/métodos , Espectrometría de Masas/métodos , Ratones , Plantas Medicinales/microbiología , Polarografía
14.
Food Chem Toxicol ; 47(10): 2407-18, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19576260

RESUMEN

The safety of a refined arachidonic acid-rich oil (RAO) was evaluated for reverse mutation, chromosome aberration and gene mutation, and in a 90-day Wistar rat feeding study with in utero exposure. The results of the genotoxicity assays were all negative. The in utero phase of the 90-day study involved dietary exposure to 0.5%, 1.5% and 5% RAO and two controls diets, a standard feed low-fat diet and a high-fat diet supplemented with 5% corn oil. This exposure covered four-weeks prior to mating, through mating, gestation and lactation until offspring (F(1)) weaning. A subsequent 90-day feeding study in the F(1) rats evaluated the same test and control diets. Statistically significant effects were seen for selected histopathology, clinical chemistry and organ weight endpoints; however, other than increased absolute and relative monocytes seen in both sexes of high-dose rats, the observations were not attributed to treatment for one or more reasons. Based on these findings, no adverse treatment-related effects for RAO were seen at up to 5% in the diet, equivalent to an overall average RAO intake of 3170 mg/kg bwt/day. These and similar findings for other refined ARA-rich oils establish a strong body of evidence for the safety of this RAO.


Asunto(s)
Ácido Araquidónico/toxicidad , Grasas Insaturadas en la Dieta/toxicidad , Exposición Materna/efectos adversos , Monocitos/efectos de los fármacos , Mutágenos/toxicidad , Reproducción/efectos de los fármacos , Animales , Ácido Araquidónico/clasificación , Ácido Araquidónico/metabolismo , Células CHO , Línea Celular Tumoral , Aberraciones Cromosómicas/inducido químicamente , Cricetinae , Cricetulus , Grasas Insaturadas en la Dieta/clasificación , Grasas Insaturadas en la Dieta/metabolismo , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Femenino , Leucemia L5178/tratamiento farmacológico , Leucemia L5178/enzimología , Leucemia L5178/genética , Masculino , Monocitos/patología , Pruebas de Mutagenicidad , Mutágenos/clasificación , Mutágenos/metabolismo , Nivel sin Efectos Adversos Observados , Embarazo , Efectos Tardíos de la Exposición Prenatal , Ratas , Ratas Wistar , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/genética , Timidina Quinasa/genética , Timidina Quinasa/metabolismo
15.
In Vivo ; 23(1): 41-8, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19368123

RESUMEN

The aim of the present study was to investigate the anticancer properties of five alkaloids isolated from Amaryllidaceae, including the inhibitory effect on P-glycoprotein (P-gp) and the apoptosis-inducing capacity. The tested alkaloids were evaluated for their multidrug resistance (MDR)-reversing activity on human MDR1-gene-transfected L5178 mouse lymphoma cells, using the rhodamine-123 (Rh-123) assay. Trisphaeridine and pretazettine increased the intracellular Rh-123 concentration 30- and 50-fold, respectively, as compared to the non-treated cells, and 2-O-acetyllycorine and trisphaeridine were demonstrated by means of the checkerboard method to enhance the antiproliferative activity of doxorubicin on L5178 MDR mouse lymphoma cells. The MTT assay revealed that pretazettine, trisphaeridine and 2-O-acetyllycorine displayed excellent antiproliferative effects on both the human and the mouse cell lines. The apoptosis-inducing activities of selected agents (2-O-acetyllycorine and trisphaeridine) were measured via acridine orange and ethidium bromide dual staining and flow cytometry of the subG1 population.


Asunto(s)
Alcaloides de Amaryllidaceae/farmacología , Antineoplásicos/farmacología , Leucemia L5178/tratamiento farmacológico , Liliaceae/química , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Animales , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Fragmentación del ADN , Dioxoles/farmacología , Doxorrubicina/farmacología , Combinación de Medicamentos , Ensayos de Selección de Medicamentos Antitumorales , Sinergismo Farmacológico , Humanos , Leucemia L5178/metabolismo , Leucemia L5178/patología , Ratones , Fenantridinas/farmacología , Extractos Vegetales/farmacología , Rodamina 123/metabolismo , Transfección
16.
Anticancer Res ; 28(5A): 2737-43, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19035304

RESUMEN

The aim of the present study was to investigate the anticancer properties of a set of furanoacridone alkaloids, arborinine and evoxanthine, including the inhibitory effect of P-glycoprotein (Pgp) and the apoptosis-inducing capacity. The tested alkaloids were evaluated for multidrug resistance (MDR)-reversing activity on human Pgp-transfected L5178 mouse lymphoma cells, using the rhodamine-123 (Rh-123) assay. The antiproliferative effects of natural compounds and their interactions with doxorubicin were determined in MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays. Apoptosis-inducing activity was additionally measured by means of dual annexin V and propidium iodide staining. RT-PCR was used to test the expression of Pgp mRNA after acridone treatment. All of the acridones investigated increased the accumulation of Rh-123. Gravacridonetriol and gravacridonediol monomethyl ether increased the antiproliferative effect of doxorubicin on resistant L5178 cells. Treatment with these agents resulted in a decrease in Pgp mRNA levels. Naturally occurring acridone alkaloids exhibit a beneficial combination of anticancer effects and, accordingly, the acridone skeleton can be considered useful in the design of novel antiproliferative agents.


Asunto(s)
Acridonas/farmacología , Alcaloides/farmacología , Leucemia L5178/tratamiento farmacológico , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/biosíntesis , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Animales , Anexina A5 , Apoptosis/efectos de los fármacos , Citometría de Flujo , Leucemia L5178/metabolismo , Ratones , Propidio , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Rodamina 123/farmacocinética , Coloración y Etiquetado/métodos
17.
Phytochemistry ; 69(8): 1716-25, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18400237

RESUMEN

Extracts of cultures grown in liquid or on solid rice media of the fungal endophyte Ampelomyces sp. isolated from the medicinal plant Urospermum picroides exhibited considerable cytotoxic activity when tested in vitro against L5178Y cells. Chromatographic separation yielded 14 natural products that were unequivocally identified based on their 1H and 13C NMR as well as mass spectra and comparison with previously published data. Six compounds (2, 4, 5, 7, 9 and 11) were natural products. Both fungal extracts differed considerably in their secondary metabolites. The extract obtained from liquid cultures afforded a pyrone (2) and sulfated anthraquinones (7 and 9) along with the known compounds 1, 3, 6 and 8. When grown on solid rice medium the fungus yielded three compounds 4, 5 and 11 in addition to several known metabolites including 6, 8, 10, 12, 13 and 14. Compounds 4, 8 and 10 showed the strongest cytotoxic activity against L5178Y cells with EC50 values ranging from 0.2-7.3microg/ml. Furthermore, 8 and 10 displayed antimicrobial activity against the Gram-positive pathogens, Staphylococcus aureus, S. epidermidis and Enterococcus faecalis at minimal inhibitory concentrations (MIC) of 12.5microg/ml and 12.5-25microg/ml, respectively. Interestingly, 6 and 8 were also identified as constituents of an extract derived from a healthy plant sample of the host plant U. picroides thereby indicating that the production of bioactive natural products by the endophyte proceeds also under in situ conditions within the host plant.


Asunto(s)
Antiinfecciosos/aislamiento & purificación , Ascomicetos/química , Asteraceae/microbiología , Citotoxinas/aislamiento & purificación , Leucemia L5178/tratamiento farmacológico , Plantas Medicinales/microbiología , Animales , Antiinfecciosos/química , Antiinfecciosos/farmacología , Ascomicetos/crecimiento & desarrollo , Ascomicetos/metabolismo , Bacterias/efectos de los fármacos , Línea Celular Tumoral , Citotoxinas/química , Citotoxinas/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Cromatografía de Gases y Espectrometría de Masas , Ratones , Pruebas de Sensibilidad Microbiana , Estructura Molecular
18.
Food Chem Toxicol ; 46(6): 1949-59, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18353517

RESUMEN

Agaricus blazei Murrill, an edible mushroom, is used as a functional food due to medicinal effects of (1-->6)-beta-D-glucan protein complex which has been shown to have anti tumour activity in mice. A 13week oral subchronic study in rats performed at 500, 1000 or 2000mg/kg/day caused, at the highest dose, reduced erythrocyte numbers and high mean cell volume in males, high creatinine and urea concentrations in both sexes and low spleen weights in females, but no histopathological change. The findings suggested low level chronic toxicity at 2000mg/kg/day and a no observed adverse effect level (NOAEL) of 1000mg/kg/day. Genotoxicity tests on the aqueous extract were negative in the bacterial reverse mutation test, either with or without S9 mix, up to 5000microg/plate and in a rat bone marrow micronucleus test up to 2g/kg bodyweight. The extract was positive at acceptable levels of toxicity in an L5178Y mouse lymphoma assay following 24h exposure in the absence of S9 and this was associated with an increase in the number of small colonies, suggesting possible clastogenic activity or aneuploidy, rather than point mutation. The aqueous extract of A. blazei is therefore of low subchronic toxicity and did not cause any direct effect upon the DNA molecule and the weak positive in the L5178 mouse lymphoma test was likely due to large deletions or the loss of the whole chromosomes rather than to direct damage to the DNA.


Asunto(s)
Agaricus/química , Antibióticos Antineoplásicos/toxicidad , Mutágenos/toxicidad , Animales , Recuento de Células Sanguíneas , Peso Corporal/efectos de los fármacos , Línea Celular , Dieta , Ensayos de Selección de Medicamentos Antitumorales , Ingestión de Alimentos/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Femenino , Cuerpos Fructíferos de los Hongos/química , Leucemia L5178/tratamiento farmacológico , Masculino , Ratones , Pruebas de Micronúcleos , Pruebas de Mutagenicidad , Nivel sin Efectos Adversos Observados , Ratas , Ratas Sprague-Dawley , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/genética , Caracteres Sexuales
19.
In Vivo ; 21(2): 429-33, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17436599

RESUMEN

Novel heat shock protein 90 inhibitor peptide derivatives [D- Trp-Phe-D- Trp-Leu-AMB (1), p-HOPA-D- TrpPhe-D-Trp-Leu-psi(CH2NH)-Leu-NH2 (2), D-Trp-Phe-D-Trp-OH (3), Suc-D-Trp-Phe-D-Trp-Leu-AMB (4), D-Tyr-Phe-D-Trp-Leu-AMB (5), D-Arg-D-Trp-Phe-D-Trp-Leu-Leu-NH2 (6), Leu-psi(CH2NH)-Leu-NH2x2HCl (7), Phe-Trp-Phe-Trp-Leu-Leu-NH2 (8), Tyr-Trp-Phe-Trp-Leu-Leu-NH2 (9) and Tyr-D- Trp-Phe-D-Trp-Leu-Leu-NH2 (10)] were synthetized, and their ability to reverse multidrug resistance (MDR) was studied. Peptide derivatives 1, 4 and 5, with D-Trp or D-Tyr residues in the N-terminal position caused a marked inhibition of MDR in cancer cells. These MDR inhibitor compounds and epirubicin were demonstrated to have additive and synergistic antiproliferative effects in checkerboard experiments on human MDR1 gene-transfected mouse lymphoma cells in vitro. It is suggested that the MDR reversal effects of these anticancer peptide derivatives, together with their antiproliferative effects on lung cancer cells, may open up new horizons in cancer chemotherapy.


Asunto(s)
Proteínas HSP90 de Choque Térmico/uso terapéutico , Fragmentos de Péptidos/uso terapéutico , Animales , Antineoplásicos/uso terapéutico , Línea Celular Tumoral , Resistencia a Múltiples Medicamentos/efectos de los fármacos , Proteínas HSP90 de Choque Térmico/química , Humanos , Leucemia L5178/tratamiento farmacológico , Ratones
20.
Anticancer Res ; 26(1A): 367-74, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16475720

RESUMEN

The development of multidrug resistance (MDR) causes difficulties in the chemotherapy of of human cancer. Investigation of the possibility of reversal of MDR has been greatly aided by the use of cell lines with acquired resitance to anticancer agents in vitro or transfected with the mdrl gene. The aim of this study was to examine new perspectives of chemotherapy focused on natural, carotenoid compounds, in connection with the modification of MDR. The function of the MDR protein was examined via the R123 drug accumulation of both cell lines in the presence of carotenoids. The fluorescence of the cell population was measured by flow cytometry. The most effective resistance modifiers Monoepoxy-beta-carotene, (SS, 8S)-capsochrome, (8'S) Luteoxanthin, (9Z)-Violaxanthin, (9Z)-Zeaxanthin, (13Z)-Zeaxanthin were assayed for their antiproliferative effects in combination with the anti-cancer drug epirubicin. (13Z)-Zeaxanthin was able to enhance the antiproliferative effect on human mdrl gene transfected mouse lymphoma and anthracycline resistant human breast cancer cell line MCF7. (8'S)-luteoxanthin, (5S, 8S)-capsochrome and (9Z)-zeaxanthin treatment revealed synergism with epirubicin on resistant mouse lymphoma. The enhanced antiproliferative activity of epirubicin combinated with (9Z)-Violaxanthin was more significant on MCF7 cells resistant to anthracycline.


Asunto(s)
Carotenoides/farmacología , Resistencia a Múltiples Medicamentos/efectos de los fármacos , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/biosíntesis , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Animales , Doxorrubicina/farmacología , Resistencia a Antineoplásicos , Sinergismo Farmacológico , Leucemia L5178/tratamiento farmacológico , Leucemia L5178/metabolismo , Ratones , Estereoisomerismo , Relación Estructura-Actividad , Verapamilo/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA